Revenue: The sum of all revenue fields included for a company's operating activities.
Taro Pharmaceutical Industries Ltd. (TARO) had Revenue of $157.15M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$157.15M |
$20.21M |
|
$77.26M |
|
$79.88M |
|
$141.26M |
|
$15.88M |
|
$17.46M |
|
$33.34M |
|
$33.34M |
|
$20.21M |
|
$20.21M |
|
$20.21M |
|
$20.21M |
|
$15.88M |
|
$20.04M |
|
37.59M |
|
37.59M |
|
$0.54 |
|
$0.54 |
|
| Balance Sheet Financials | |
$1.35B |
|
$218.38M |
|
$815.77M |
|
$2.16B |
|
$374.06M |
|
-- |
|
$10.03M |
|
$384.09M |
|
-- |
|
$1.76B |
|
$1.78B |
|
-- |
|
| Cash Flow Statement Financials | |
$86.22M |
|
$141.54M |
|
-- |
|
$154.50M |
|
$382.41M |
|
$227.91M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
50.83% |
|
10.11% |
|
10.11% |
|
-- |
|
21.22% |
|
12.86% |
|
$37.99M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.36 |
|
0.68 |
|
131.94 |
|
-- |
|
1.15% |
|
0.93% |
|
1.14% |
|
-- |
|
$1.01 |
|
$2.29 |
|